Zobrazeno 1 - 10
of 47
pro vyhledávání: '"Jozsef, Timar"'
Autor:
Melinda Varadi, Nikolett Nagy, Henning Reis, Boris Hadaschik, Christian Niedworok, Orsolya Modos, Attila Szendroi, Jason Ablat, Peter C. Black, David Keresztes, Anita Csizmarik, Csilla Olah, Nadine T. Gaisa, Andras Kiss, Jozsef Timar, Erika Toth, Erzsebet Csernak, Arpad Gerstner, Vinay Mittal, Sofia Karkampouna, Marianna Kruithof de Julio, Balazs Gyorffy, Gabor Bedics, Michael Rink, Margit Fisch, Peter Nyirady, Tibor Szarvas
Publikováno v:
Cancer Medicine, Vol 12, Iss 7, Pp 9041-9054 (2023)
Abstract Objective Administration of targeted therapies provides a promising treatment strategy for urachal adenocarcinoma (UrC) or primary bladder adenocarcinoma (PBAC); however, the selection of appropriate drugs remains difficult. Here, we aimed t
Externí odkaz:
https://doaj.org/article/e41fec3667254bd390a37fade443482d
Autor:
Miklos Diossy, Zsofia Sztupinszki, Judit Borcsok, Marcin Krzystanek, Viktoria Tisza, Sandor Spisak, Orsolya Rusz, Jozsef Timar, István Csabai, Janos Fillinger, Judit Moldvay, Anders Gorm Pedersen, David Szuts, Zoltan Szallasi
Publikováno v:
npj Precision Oncology, Vol 5, Iss 1, Pp 1-8 (2021)
Abstract PARP inhibitors are approved for the treatment of solid tumor types that frequently harbor alterations in the key homologous recombination (HR) genes, BRCA1/2. Other tumor types, such as lung cancer, may also be HR deficient, but the frequen
Externí odkaz:
https://doaj.org/article/406462c44b26424ba7040c4796c0ef2d
Autor:
Ales Ryska, Peter Berzinec, Luka Brcic, Tanja Cufer, Rafal Dziadziuszko, Maya Gottfried, Ilona Kovalszky, Włodzimierz Olszewski, Buge Oz, Lukas Plank, Jozsef Timar
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-8 (2018)
Abstract Background The introduction of targeted treatments for subsets of non-small cell lung cancer (NSCLC) has highlighted the importance of accurate molecular diagnosis to determine if an actionable genetic alteration is present. Few data are ava
Externí odkaz:
https://doaj.org/article/70132703664147e4824167157122fb1b
Autor:
Aniko Keller-Pinter, Bettina Ughy, Monika Domoki, Aladar Pettko-Szandtner, Tamas Letoha, Jozsef Tovari, Jozsef Timar, Laszlo Szilak
Publikováno v:
PLoS ONE, Vol 12, Iss 11, p e0187094 (2017)
The small GTPases of the Rho family comprising RhoA, Rac1 and Cdc42 function as molecular switches controlling several essential biochemical pathways in eukaryotic cells. Their activity is cycling between an active GTP-bound and an inactive GDP-bound
Externí odkaz:
https://doaj.org/article/1bb2f9035c1945beab3d6c94b326feed
Autor:
Orsolya Pipek, Laura Vizkeleti, Viktória Doma, Donát Alpár, Csaba Bödör, Sarolta Kárpáti, Jozsef Timar
Publikováno v:
Cancers; Volume 15; Issue 6; Pages: 1712
The genetic makeup of the triple-wild-type melanoma (BRAF, NRAS and NF1) has been known for some time, but those studies grouped together rare histopathological versions with common ones, as well as mucosal and even uveal ones. Here we used whole gen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ebfe5fe84435ee143d1cbf997202b9a
https://doi.org/10.3390/cancers15061712
https://doi.org/10.3390/cancers15061712
Publikováno v:
PLoS ONE, Vol 8, Iss 1, p e53883 (2013)
The role of CD44 in the progression of human melanoma has mostly been characterised by qualitative changes in expression of its individual variable exons. These exons however, may be expressed to form a number of molecules, the alternative splice var
Externí odkaz:
https://doaj.org/article/6d2eb47dbf11496fab1ce670c93744f0
Autor:
Ales Ryska, Berzinec, Peter, Brcic, Luka, Cufer, Tanja, Dziadziuszko, Rafal, Gottfried, Maya, Kovalszky, Ilona, WĹOdzimierz Olszewski, Buge Oz, Plank, Lukas, Jozsef Timar
Questionnaire addressing issues of molecular testing and NSCLC management. Questionnaire was provided to 59 specialists (epidemiologists, oncologists, pulmonologists, and pathologists) from nine CEE countries requesting information. (PDF 191Â kb)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::086c9230dff56b51fc39de8d3fd8d44c
Autor:
Sándor, Paku, Viktoria, Laszlo, Katalin, Dezso, Peter, Nagy, Mir Alireza, Hoda, Walter, Klepetko, Ferenc, Renyi-Vamos, Jozsef, Timar, Andrew R, Reynolds, Balazs, Dome
Publikováno v:
The Journal of pathology. 241(4)
The development of lung metastasis is a significant negative prognostic factor for cancer patients. The extravasation phase of lung metastasis involves interactions of tumour cells with the pulmonary endothelium. These interactions may have broad bio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4acbd3c73b423f68e49de6e2fa8c2244
https://pubmed.ncbi.nlm.nih.gov/28026875
https://pubmed.ncbi.nlm.nih.gov/28026875
Autor:
Diana, Brauswetter, Ede, Birtalan, Kornel, Danos, Adrienn, Kocsis, Tibor, Krenacs, Jozsef, Timar, Reka, Mihalyi, Dorottya, Horcsik, Gabor, Polony, Laszlo, Tamas, Istvan, Petak
Publikováno v:
European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery. 274(4)
Head and neck cancer treatment protocols still lack well-established biomarkers of prognostic and predictive value. It is well known that human papillomavirus (HPV)-related and non-HPV-related oropharyngeal cancers are distinct entities concerning tu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4fb822fd6aa196f3e67eacb1fbf9c81f
https://pubmed.ncbi.nlm.nih.gov/27999998
https://pubmed.ncbi.nlm.nih.gov/27999998
Autor:
Zsolt Lörincz, Balazs Hegedus, Ferenc Rényi-Vámos, Jozsef Timar, Balazs Dome, Judit Berta, János Varga, József Tóvári, Gyula Ostoros, Sándor Paku, István Kenessey, Walter Klepetko, Hendrik Jan Ankersmit, Anita Rozsas, Judit Dobos
Publikováno v:
Journal of Thoracic Oncology. 5:1120-1129
Introduction The recently discovered bioactive peptide, apelin, has been demonstrated to stimulate angiogenesis in various experimental systems. However, its clinical significance and role in tumor vascularization have not yet been investigated in a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a466ec62dc4463a047f931eccf23359
https://doi.org/10.1097/jto.0b013e3181e2c1ff
https://doi.org/10.1097/jto.0b013e3181e2c1ff